Realising the recurrent savings and associated benefits of digital healthcare

Join in a practical review of validated geriatric assessment tools and learn how to incorporate them into your oncology practice. Logistics, including who can and should administer the assessment will also be included.

In this on-demand webinar, we take a closer look at two key trends currently reshaping our industry: consumerism and digitization. We’ll discuss how providers can capitalize on these trends to simultaneously improve patient satisfaction and cash flow.

Current research demonstrates only 23% of newly licensed RNs are able to think at entry level expectations. Additionally, 68% of errors made by nurses are due to poor decision-making skills. In order to reverse these staggering statistics, we must focus on continuing education to advance competency and use proven data to identify development needs and accurately measure progress towards success.

Small cell lung cancer (SCLC) is aggressive and often difficult to treat, but many patients may have new hope. On August 17, 2018, the FDA approved the first immunotherapy the checkpoint inhibitor nivolumab (Opdivo, Bristol-Myers Squibb for patients with small cell lung cancer. Since this approval, there has been renewed focus on how to make different immunotherapies work for a disease which typicallly comprises 10-15% of all lung cancer cases. In this webinar for patients and caregivers, Matthew Hellmann, M.D., of Memorial Sloan Kettering Cancer Center discusses the new FDA approval, clinical trials, and potential treatments for patients with small cell lung cancer.